Clinical Trials Browser

Recurrence × apatinib × Clear all

NCT04047017 2021-07-30

GTN

Phase 2 Completed

Recurrence, Gestational Trophoblastic Disease

NCT04476459 2021-03-15

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

Phase 1/2 Unknown

Recurrence, Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic

NCT03913182 2020-02-05

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Recurrence

NCT03376958 2019-07-25

Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma

Phase 4 Completed

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03298074 2017-09-29

Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer

Phase 2 Unknown

Ovarian Neoplasms, Recurrence

NCT03026881 2017-03-07

A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients

Phase 1 Unknown

Gastrointestinal

Recurrence, Stomach Neoplasms